 NWBO  KCG  Merck  BMY  KITE Max Keiser at minute 9:45 states clearing a short sell can take up to a year or more. 

Merck top dog in I-O field with Keytruda juggernaut - FiercePharma  Merck  BMY
With ASCO data tallied, Bristol-Myers loses ground to Merck in I-O field  BMY  Merck
with pics!
J&J woos Merck’s Mathai Mammen to helm of pharma R&D, Hait takes over on external innovation
 JNJ  Merck

Credit Suisse Group AG Analysts Give Merck & Co., Inc.  Merck a  72.00 Price Target 
 mikegoodma  BMY under 52  PFE under 32  Merck weak 64 - all down recently - not good
ICYMI: Latest Ebola outbreak a reminder of continued need for vaccines, drugs  NIH  Ebola  Merck  JNJ  REGN  pharma
 JNJ woos Merck’s Mathai Mammen to helm of pharma R&D, Hait takes over on external innovation
 Merck

Breast cancer data at  asco17 portends shifting fortunes for  AZN,  Merck  RHHBY: 
Merck & Co.’s  Merck Buy Rating Reaffirmed at BMO Capital Markets 
 JNJ says Bill Hait to take new role heading external innovation company-wide, and  Merck's Mathai Mammen will head pharma R&D
SELL  Merck 64.06, COVER  MYL 39.34, SELL  TAP 89.78. More stock tips & details at: 
Merck & Co., Inc.  Merck Shares Sold by Telemus Capital LLC  stocks
Merck & Co., Inc.  Merck Shares Sold by Telemus Capital LLC 
Capital Investment Advisors LLC Acquires 2,878 Shares of Merck & Co., Inc.  Merck 
Here's a Little Valeant What If Fun!  VRX  AGN  MYL  Merck  JNJ  TWTR  IeP  HLF  KO  PeP  SNAP  Apple  TSLA  MSFT… 
 NWBO  KCG  Merck  BMY  KITE  JUNO  CLDX  AZN Curious how manipulative naked shorting is done? Watch this video & see

Valeant & My Road To Profit & Progress  VRX  AGN  MYL  Merck  JNJ  TWTR  IeP  HLF  KO  PeP  SNAP  Apple  TSLA  MSFT… 
Merck & Co., Inc.  Merck Given a  72.00 Price Target at Credit Suisse Group AG 
Whale Feeding on Valeant!  VRX  AGN  MYL  Merck  JNJ  TWTR  IeP  HLF  KO  PeP  SNAP  Apple  TSLA  MSFT  SHAK  PYPL… 
Pass it on! Reason for no insider buys. Partnership!?  exas  pfe  jnj  mrk  gsk  dvax  rnn 
 ASCO soundbites: Weekend insights from some of  pharma's finest  oncology wordsmiths  biotech  RHHBY  Merck  BMY 
With  ASCO data tallied,  BMY loses ground to  Merck in  IO field  immunooncology  biotech  lungcancer  checkpoint 
What's Driving Pfizer Now  PFE  JNJ  LLY  Merck
My Other Progess Was Wrong. 0 Needed!  VRX  AGN  MYL  Merck  JNJ  TWTR  IeP  HLF  KO  PeP  SNAP  Apple  TSLA  MSFT… 
Some Adjs. On My Valeant 2017 Progress!  VRX  AGN  MYL  Merck  JNJ  TWTR  IeP  HLF  KO  PeP  SNAP  Apple  TSLA  MSFT… 
Credit Suisse Group AG Reiterates “ 72.00” Price Target for Merck & Co., Inc.  Merck 
FDA approves Keytruda in 2 bladder cancer indications  Merck  bladder  cancer 
 cytr got another email from IR. Partnerships?  pfe  jnj  mrk  gsk  exas  dvax  rnn 
<< The best stock picking services reviewed!  vrx  agn  myl  mrk  ko
 Merck's Cancer Drug Keytruda Positive in Clinical Studies . Read more:  Merck
Bottom of range from open:  SN -100,  ETN -96,  PE -94,  BHI  CCL  MDRX  Merck -91,  AMBoeing  APC  EMR -90,  AES  POT  X -89,  P -88
Merck top dog in I-O field with Keytruda juggernaut - FiercePharma  Merck  BMY  sitifatimah  malaysia  financialplan…
With ASCO data tallied, Bristol-Myers loses ground to Merck in I-O field:  BMY  Merck  ASCO17  pharma
 Merck acquires five bispecific  immunooncology antibodies from UK biotech company F-STAR for upfront EUR 115m 
Months after trial setbacks, Merck licenses Teijin Alzheimer's candidate  Merck  Merck… 
With  ASCO17 data tallied, Bristol-Myers loses ground to Merck in I-O field  BMY  Merck
ICYMI: Latest Ebola outbreak a reminder of continued need for vaccines, drugs  NIH  Ebola  pharma  Merck  JNJ  REGN
Merck Top news - Jun 7th, 2017  Merck 
 AndyBiotech  Merck's CTLA-4 MK-1308 to be tested in multi-arm, ~148 pt. P1 combo with Keytruda; Several NSCLC focuse… 
Merck KGaA's neutral rating reiterated at JPMorgan Chase & Co..  Merck  Merck
Roivant launches Urovant with phase 3  Merck med  urinaryfrequency  urologicdisorders  Ramaswamy  biotech  pharma 
I Heard it First From Al Kingsley- Buy Means Sell!  VRX  AGN  Teva  MYL  Merck  JNJ  ACAD  JAZZ  MNK  egrx  endp  TWTR  BRK  IeP  HZNP  FLZN
Love! 2 Months Ago Now! Must Be Torn!  VRX  AGN  Teva  MYL  Merck  JNJ  ACAD  JAZZ  MNK  egrx  endp  TWTR  BRK  IeP… 
 BMY  Opdivo,  Merck  Keytruda lead their class in  cancervaccine combo studies: report  biotech  GSK  RHHBY  PFE 
Dont underestimate  Merck's vaccine business says CEO. Read more:  Merck
It's Only A Matter of Time Before The Stock Price Catches Up & Likely Not Much Time!  VRX  AGN  MYL  Merck  KO  PeP… 
 nvax surging nearly 20% on phase II data.  cytr  dvax  kerk  pfe  jnj  mrk  gsk  shpg  exas 
ICYMI: Latest Ebola outbreak a reminder of continued need for vaccines, drugs  NIH  Ebola  pharma  biotech  Merck  JNJ
Valeant's Tale of Two Stories!  VRX  AGN  MYL  Merck  TWTR  TSLA  Apple  BRK  IeP  fb  tst  GILD  FLXN  JAZZ  PRGO… 
Bristol-Myers Fails To Stem The Losses  Merck  INCY  BMY check out TICKER SYMBOL  DCSA 
Bristol-Myers Fails To Stem The Losses  Merck  INCY  BMY OMG-STOCK SYMBOL DCSA 
Bristol-Myers Fails To Stem The Losses  Merck  INCY  BMY
Solid Progress For IDO Inhibitors  Merck  BMY  INCY  NLNK  RHHBY  VRX OMG-STOCK SYMBOL DCSA 
 Merck  BMY  INCY:

Solid Progress For IDO Inhibitors:


Solid Progress For IDO Inhibitors  Merck  BMY  INCY  NLNK  RHHBY  VRX check out TICKER SYMBOL  DCSA www.docasain…
Solid Progress For IDO Inhibitors  Merck  BMY  INCY  NLNK  RHHBY  VRX
Latest Ebola outbreak a reminder of continued need for vaccines, drugs  NIH  Merck  JNJ  GILD  REGN  GSK  FUJIY  Ebola
 Merck CEO: Don’t underestimate Merck's vaccine business,’. Humbled by the great endorsement of  moderna_tx products  
 bradloncar  BrianSkorney time to revisit cash pile slide - imho action coming -how can it not  Merck  BMY  IBB  CELG… 
'Don't underestimate  Merck's vaccine business,' says CEO. Read more:  Merck
An Unprecedented FDA Approval Bodes Well for this Drug Stock  themotleyfool  stocks  Merck,  BMY 
By itself it is good! Take the breaks off and you will see unheard of response rates!  It's coming.  nwbo  kite… 
I Know I've Been Wrong on Valeant BUT NOW is the Time To BUY!  VRX  AGN  MYL  Merck  TWTR  Apple  GILD  JAZZ  PRGO… 
 WFC Nor GimmeCredit Will Tell You But Valeant's Term Loan Hit a Record High!  VRX  AGN  MYL  Merck  TWTR  Apple  GILD… 
